New combined treatment shows promise in hepatocellular carcinoma

(IDIBELL-Bellvitge Biomedical Research Institute) New combined treatment shows promise in Hepatocellular Carcinoma. A combination of mTOR inhibitors and Phenformin leads to an increase in overall survival.